Menu
Using real-world multimodal data to develop precision medicines can be challenging. Our cloud-based SOPHiA DDM™ for Multimodal uses machine learning to integrate and standardize data, enabling rapid discovery of complex signatures and faster patient stratification.
Clinical Trial Optimization
Market Access Strategy
“Through this collaboration, we aim to enable the widespread application of precision medicine in oncology across Africa, and thus contributing to the improvement of patient outcomes across the African continent.
“SOPHiA GENETICS was a natural choice when our RNA‑seq workflows faced unforeseen challenges. Their commitment to understanding our unique needs and seamlessly co‑creating a bespoke solution from the ground up ensured a swift return to normal operations. With SOPHiA GENETICS, efficient communication and tailored innovation aren’t just promises; they’re the foundation of our continued success.”
“SOPHiA GENETICS and Clinisys impressed us with their meticulous approach, deep understanding of the subject matter, and their ability to foresee the big picture implications of their work. Their thoughtful commitment greatly reduced data entry errors and the need to rerun complex dataset analyses.”
“The combined drive for quality is, in my experience, mastered by the automation partnership between SOPHiA GENETICS and Hamilton. The SOPHiA GENETICS™ Applications with the Hamilton Clinical NGS STARlet provides the robustness and reproducibility we need in our daily NGS workflow.”
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
